Sanjeev Narula - 12 Aug 2024 Form 4 Insider Report for Intra-Cellular Therapies, Inc. (ITCI)

Role
Executive Vice President & CFO
Signature
/s/ John P. Condon, Attorney-in-fact
Issuer symbol
ITCI
Transactions as of
12 Aug 2024
Net transactions value
$0
Form type
4
Filing time
14 Aug 2024, 18:01:19 UTC
Previous filing
06 Mar 2023
Next filing
04 Feb 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ITCI Stock Option (right to buy) Award $0 +17,251 $0.000000 17,251 12 Aug 2024 Common Stock 17,251 $74.90 Direct F1
transaction ITCI Restricted Stock Units Award $0 +35,046 $0.000000 35,046 12 Aug 2024 Common Stock 35,046 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests as to one third of the shares on August 12, 2025, one third of the shares on August 12, 2026 and one third of the shares on August 12, 2027.
F2 Each restricted stock unit represents a contingent right to receive one share of common stock.
F3 The restricted stock units vest as to one third of the shares on August 12, 2025, one third of the shares on August 12, 2026 and one third of the shares on August 12, 2027.